Osetomics, co-founded by Annamarie D. Horan, MPA, PhD from Penn Medicine, has appointed global medical device leader Mark Boyle as its new Chief Executive Officer. The company is currently raising $8.5 million to support further development of its diagnostic and prognostic tools for the treatment of various musculoskeletal and orthopedic conditions. To learn more, contact Mark Boyle.